These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34713519)
21. Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001). Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak AR; Chen EX; Jang R; O'Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR Invest New Drugs; 2016 Oct; 34(5):575-83. PubMed ID: 27289242 [TBL] [Abstract][Full Text] [Related]
22. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176 [TBL] [Abstract][Full Text] [Related]
23. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer. Chang CL; Yuan KS; Wu SY Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614 [TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial. Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ; Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376 [TBL] [Abstract][Full Text] [Related]
25. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Enokida T; Ogawa T; Homma A; Okami K; Minami S; Nakanome A; Shimizu Y; Maki D; Ueda Y; Fujisawa T; Motegi A; Ohkoshi A; Taguchi J; Ebisumoto K; Nomura S; Okano S; Tahara M Cancer Med; 2020 Mar; 9(5):1671-1682. PubMed ID: 31943834 [TBL] [Abstract][Full Text] [Related]
26. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial. Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659 [TBL] [Abstract][Full Text] [Related]
27. A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. Keam B; Lee KW; Lee SH; Kim JS; Kim JH; Wu HG; Eom KY; Kim S; Ahn SH; Chung EJ; Kwon SK; Jeong WJ; Jung YH; Kim JW; Heo DS Oncologist; 2019 Jun; 24(6):751-e231. PubMed ID: 30796155 [TBL] [Abstract][Full Text] [Related]
28. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651 [TBL] [Abstract][Full Text] [Related]
29. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474 [TBL] [Abstract][Full Text] [Related]
30. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection. Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313 [TBL] [Abstract][Full Text] [Related]
31. The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis. Jacinto JK; Co J; Mejia MB; Regala EE Br J Radiol; 2017 Nov; 90(1079):20170442. PubMed ID: 29053029 [TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Mesía R; Henke M; Fortin A; Minn H; Yunes Ancona AC; Cmelak A; Markowitz AB; Hotte SJ; Singh S; Chan AT; Merlano MC; Skladowski K; Zhang A; Oliner KS; VanderWalde A; Giralt J Lancet Oncol; 2015 Feb; 16(2):208-20. PubMed ID: 25596660 [TBL] [Abstract][Full Text] [Related]
33. Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Le Tourneau C; Tao Y; Gomez-Roca C; Cristina V; Borcoman E; Deutsch E; Bahleda R; Calugaru V; Modesto A; Rouits E; Gollmer K; Vuagniaux G; Crompton P; Zanna C; Szyldergemajn S; Delord JP; Bourhis J Clin Cancer Res; 2020 Dec; 26(24):6429-6436. PubMed ID: 32994295 [TBL] [Abstract][Full Text] [Related]
34. [Observance and results of concurrent chemoradiotherapy after induction chemotherapy by docetaxel, cisplatin and 5-fluoro-uracil for locally advanced head and neck cancers]. Calderon B; Guerder C; Resbeut M; Fakhry N; Dupuis C; Cowen D Cancer Radiother; 2016 Apr; 20(2):83-90. PubMed ID: 26969244 [TBL] [Abstract][Full Text] [Related]
35. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status. Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Hanemaaijer SH; Kok IC; Fehrmann RSN; van der Vegt B; Gietema JA; Plaat BEC; van Vugt MATM; Vergeer MR; Leemans CR; Langendijk JA; Voortman J; Buter J; Oosting SF Front Oncol; 2020; 10():761. PubMed ID: 32582534 [No Abstract] [Full Text] [Related]
37. The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma. Al-Mamgani A; de Ridder M; Navran A; Klop WM; de Boer JP; Tesselaar ME Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3757-3765. PubMed ID: 28755023 [TBL] [Abstract][Full Text] [Related]
38. 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis. Helfenstein S; Riesterer O; Meier UR; Papachristofilou A; Kasenda B; Pless M; Rothschild SI Radiat Oncol; 2019 Feb; 14(1):32. PubMed ID: 30744643 [TBL] [Abstract][Full Text] [Related]
39. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma. Yang WC; Chen CH; Tang JY; Wu CF; Liu YC; Sun Y; Lin SF Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400 [TBL] [Abstract][Full Text] [Related]
40. Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma. Fan KY; Gogineni H; Zaboli D; Lake S; Zahurak ML; Best SR; Levine MA; Tang M; Zinreich ES; Saunders JR; Califano JA; Blanco RG; Pai SI; Messing B; Ha PK Ann Surg Oncol; 2012 Jun; 19(6):1980-7. PubMed ID: 22290566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]